Τόμος 24 (2010) – Τεύχος 2 – Άρθρο 79 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 2 – Article 79 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Modulation of P-glycoprotein mediated drug transport in caco-2 cells by aloe vera phytotherapeutic products: a methodology to evaluate drug-herb interactions in clinical practice
Authors Marios Spanakis, Ioannis S. Vizirianakis and Ioannis Niopas

Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University, Thessaloniki, Greece

Citation Spanakis, M., Vizirianakis, S., Niopas, I.: Modulation of P-glycoprotein mediated drug transport in caco-2 cells by aloe vera phytotherapeutic products: a methodology to evaluate drug-herb interactions in clinical practice, Epitheorese Klin. Farmakol. Farmakokinet. 24(2): 211-213 (2010)
Publication Date 2010
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Drug-herb interactions, aloe vera, caco-2, P-gp, rhodamine-123.
Other Terms Review article
Summary Nowadays, drug-herb interactions are considered as a potential factor affecting pharmacotherapy outcomes. In this work we evaluated the modulation of P-gp function by Aloe vera juice in Caco-2 cells. The data obtained thus far indicated that Aloe vera exhibited the capability to inhibit P-gp thus raising the possibility of the emergence of adverse drug reactions (ADRs).
References 1. WHO, Research Guidelines for Evaluating the Safety and Efficacy of Herbal medicinal products., Organization, W. H., Ed., Regional Office for the Western Pacific, Manila, 1993

2. Vizirianakis S.I., Termentzi A., Niopas I., Kokkalou E.: Clinical and pharmacogenomic assessment of herb-drug interactions to improve drug delivery and pharmacovigilance. In: Plants in Traditional and Modern Medicine: Chemistry and Activity (Kokkalou E., ed.) Transworld Research Network ISBN 978-81-7895-432-5, 2010

3. Kennedy D.A., Seely D.: Clinically based evidence of drug-herb interactions: a systematic review. Expert. Opin. Drug Saf. 9: 79 (2010)

4. Li Y., Yuan H., Yang K., Xu W., Tang W., Li X.: The Structure and Functions of P-Glycoprotein. Curr. Med. Chem.: (2010)

5. Yu D.K.: The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J. Clin. Pharmacol. 39: 1203 (1999)

6. Zhang L., Reynolds K.S., Zhao P., Huang S.M.: Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicol. Appl. Pharmacol. 243: 134 (2010)

7. Artursson P.: Cell cultures as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier Syst. 8: 305 (1991)

8. Artursson P., Karlsson J.: Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175: 880 (1991)

9. FDA: Guidance for industry- Drug interactions Studies, study design, data analysis and implications for dosing and labeling, 2006

10. Reynolds T., Dweck A.C.: Aloe vera leaf gel: a review update. J. Ethnopharmacol. 68: 3 (1999)

11. Iqbal T., Kinjo M., Dowling T.C.: Determination of Rhodamine 123 in cell lysate by HPLC with visible wavelength detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 814: 259 (2005)

12. Mueller S.C., Majcher-Peszynska J., Uehleke B., Klammt S., Mundkowski R.G., Miekisch W., Sievers H., Bauer S., Frank B., Kundt G., Drewelow B.: The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose. Eur. J. Clin. Pharmacol. 62: 29 (2006)

13. Chen W., Lu Z., Viljoen A., Hamman J.: Intestinal drug transport enhancement by Aloe vera. Planta Med. 75: 587 (2009)

14. Djuv A., Nilsen O.G.: Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice: Phytother. Res. 22: 1623 (2008)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.